EurekaMag.com logo
+ Site Statistics
References:
53,623,987
Abstracts:
29,492,080
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Multicenter, randomized, controlled trial comparing high dose daily induction interferon plus ribavirin versus standard interferon alfa-2b plus ribavirin



Multicenter, randomized, controlled trial comparing high dose daily induction interferon plus ribavirin versus standard interferon alfa-2b plus ribavirin



Hepatology 32(4 Pt 2): 317A, October




(PDF 0-2 workdays service: $29.90)

Accession: 035349988

Download citation: RISBibTeXText



Related references

Treatment of Chronic Hepatitis due to Hepatitis C Virus (CH-C) in India: A Randomized Controlled Trial Comparing Daily Interferon-alfa-2b and Ribavirin with Daily Interferon-alfa-2b and Glycyrrhizin-A Multicenter Study. Journal of Clinical and Experimental Hepatology 2(1): 10-18, 2012

A randomized, controlled trial of high dose daily induction interferon plus ribavirin versus Rebetron for treatment of chronic HCV. American Journal of Gastroenterology 95(9): 2507, September, 2000

Preliminary results of a randomized multicenter controlled trial comparing interferon thrice weekly in combination with ribavirin with interferon daily in combination with ribavirin and amantadine in the treatment of chronic hepatitis C in human immune deficiency virus co-infected patients. Hepatology 36(4 Part 2): 586A, October, 2002

Daily versus thrice-weekly interferon alfa-2b plus ribavirin for the treatment of chronic hepatitis C in HIV-infected persons: a multicenter randomized controlled trial. Journal of Acquired Immune Deficiency Syndromes 35(5): 464-472, 2004

Intron a plus ribavirin for the treatment of patients with chronic hepatitis C not previously treated with interferon Comparing 3MU interferon daily and 5MU interferon TIW combined with a standard dose of ribavirin. Hepatology 32(4 Pt 2): 553A, October, 2000

A randomized trial of high dose interferon alfa-2b with or without ribavirin for chronic hepatitis C in non-responders to standard dose interferon. Gastroenterology 118(4 Suppl 2 Part 2): AASLD A148, April, 2000

ANRS HC02-RIBAVIC A randomized controlled trial of pegylated-interferon alfa-2b plus ribavirin vs interferon alfa-2b plus ribavirin for the initial treatment of chronic hepatitis C in HIV co-infected patients. Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 42: 269, 2002

High-dose interferon alfa-2b and ribavirin in patients previously treated with interferon: results of a prospective, randomized, controlled trial. Journal of Clinical Gastroenterology 34(2): 177-182, 2002

A multi-center randomized trial comparing daily induction dose interferon alpha 2b plus ribavirin followed by daily combination therapy versus standard combination therapy in treatment naive patients with chronic hepatitis C. Hepatology 32(4 Pt 2): 556A, October, 2000

Pegylated interferon alfa-2b vs standard interferon alfa-2b, plus ribavirin, for chronic hepatitis C in HIV-infected patients: a randomized controlled trial. JAMA 292(23): 2839-2848, 2004

Randomized controlled trial of interferon-A 5mU daily plus ribavirin 1000mg daily versus interferon-A 3mU tiw plus ribavirin 1000mg daily in patients with HCV who have never received previous therapy. Hepatology 32(4 Pt 2): 363A, October, 2000

Peginterferon alfa-2b plus ribavirin compared to interferon alfa-2b plus ribavirin for the treatment of chronic hepatitis C 24 Week treatment analysis of a multicenter, multinational phase III randomized controlled trial. Hepatology 32(4 Pt 2): 297A, October, 2000

Interferon induction followed by prolonged high dose IFN in combination with ribavirin for relapser HCV patients A randomized controlled multicenter Trial. Journal of Hepatology 34(Supplement 1): 147, April, 2001

A multi-center trial using daily induction dose interferon alpha 2b plus ribavirin followed by daily interferon alpha 2b + ribavirin in patients with chronic hepatitis C who have previously failed an interferon based therapy. Hepatology 32(4 Pt 2): 559A, October, 2000

Retreatment for chronic Hepatitis C of interferon non-responder patients Preliminary results of a multicenter randomized controlled trial of interferon plus ribavirin versus interferon alone. Hepatology 28(4 PART 2): 374A, 1998